undamentalytics Newsletter

Sullivan Louis W: insider trades

Director at 4 companies we cover. 2 open-market purchases and 20 sales not made under a pre-set plan, reported from January 14, 2011 to December 23, 2025.

Would copying Sullivan Louis W’s purchases have beaten the S&P 500?

Too few purchases to judge. None of their purchases has 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. After their sales, the shares moved −10.5% against the index over 12 months on average (a negative figure means selling was the right call); 58% trailed it. None of their purchases could be priced, so there is no copy portfolio.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Sullivan Louis W: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 20 +1.5% +6.6% 40% 9 1.42 0.19 No reliable evidence
Sales, 12 months after the report 19 −10.5% −12.3% 58% 8 −0.81 0.45 No reliable evidence
Sales, 12 months after the trade 19 −8.4% −7.7% 58% 8 −0.54 0.61 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
United Therapeutics Corp UTHR —07October 1, 2013December 23, 2025
Emergent Biosolutions Inc. EBS —07June 17, 2015September 4, 2020
Henry Schein HSIC —06March 16, 2011March 3, 2016
ANI Pharmaceuticals Inc ANIP —20January 14, 2011August 29, 2011

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
December 23, 2025December 22, 2025 UTHR Sale $3,047,206 +9.5%not yetnot yet
December 19, 2024December 18, 2024 UTHR Sale $9,781,753 −10.0%+25.0%+25.1%
May 6, 2024May 3, 2024 UTHR Sale $1,333,286 +20.4%+2.7%+5.8%
September 6, 2022September 2, 2022 UTHR Sale $1,109,562 +25.1%−12.5%−15.4%
May 26, 2022May 26, 2022 UTHR Sale $1,419,786 −5.2%−13.4%−14.1%
September 4, 2020September 2, 2020 EBS Sale $3,160,729 −32.4%−79.9%−71.7%
March 6, 2020March 4, 2020 EBS Sale $930,743 +12.2%+21.8%+25.8%
May 16, 2016May 12, 2016 EBS Sale $1,867,761 −42.4%−44.3%−37.2%
May 13, 2016May 11, 2016 EBS Sale $391,283 −39.4%−42.2%−38.0%
March 14, 2016March 11, 2016 EBS Sale $506,332 +23.1%−28.2%−29.0%
March 14, 2016March 10, 2016 EBS Sale $523,739 +23.1%−28.2%−30.9%
March 3, 2016March 2, 2016 HSIC Sale $1,978,374 −0.8%−19.4%−21.1%
November 19, 2015November 17, 2015 HSIC Sale $2,407,750 +14.6%−12.3%−5.0%
June 22, 2015June 18, 2015 UTHR Sale $2,784,000 −14.0%−44.7%−44.7%
June 17, 2015June 16, 2015 EBS Sale $421,608 +7.1%+22.0%+31.4%
September 2, 2014August 29, 2014 HSIC Sale $2,071,280 +10.9%+13.9%+13.9%
May 15, 2014May 13, 2014 HSIC Sale $190,029 −2.4%+6.7%+6.7%
October 1, 2013September 30, 2013 UTHR Sale $3,296,160 +23.8%+37.6%+43.6%
August 21, 2013August 20, 2013 HSIC Sale $1,558,650 +1.1%−7.5%−7.7%
August 29, 2011August 15, 2011 ANIP Purchase $26,700 not yetnot yetnot yet
March 16, 2011March 15, 2011 HSIC Sale $1,279,200 +6.1%+3.8%+3.6%
January 14, 2011January 13, 2011 ANIP Purchase $17,200 not yetnot yetnot yet

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Sullivan Louis W traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.